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Abstract
Amiodarone is an antiarrhythmic medication used to treat a number 
of irregular heartbeats. Known ocular side effects of amiodarone 
include visual loss, swelling of the optic disc without visual
deterioration and abnormal blue color vision. After discontinuation of 
amiodarone either a visual improvement or a permeant deterioration 
may result. Here we report a rare case of visual disturbance in a 
patient with a history of amiodarone treatment complaining of see-
ing colored rings around the lights after refractive surgery. After 
the discontinuation of amiodarone treatment the patient complains 
subsided.
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Introduction
Amiodarone is an antiarrhythmic medication 
used to treat and prevent a number of irregular 
heartbeats. These include ventricular tachycardia, 
ventricular fibrillation and wide complex 
tachycardia as well as atrial fibrillation and 
paroxysmal supraventricular tachycardia 1. 
Amiodarone may produce hepatotoxicity and 
symptomatic hepatic dysfunction 2. Cirrhosis, 
peripheral neurotoxicity nausea, vomiting and 
muscle weakness are also reported among 
amiodarone side effects 2. The ocular side effects 
of amiodarone may include visual loss, swelling 
of the optic disc without visual deterioration and 
abnormal blue color vision 3. After discontinuation 
of amiodarone either a visual improvement or a 
permeant deterioration may result. Here we report 
a rare case of visual disturbance in a patient with 
a history of amiodarone treatment complaining 
from seeing colored rings around the lights after 
refractive surgery.
Case Report
A 39 year male patient who had undergone re-
fractive surgery was referred with chief com-
plain of seeing colored rings around the lights, 
and claimed that they have appeared after sur-
gery. The ophthalmologist checked the medi-
cal record of the patient and no specific con-
cern was found. The patient eye was examined 
and the funduscopy was normal. Furthermore 
the fluorescein angiography did not show no-
ticeable changes. The ophthalmologist asked 
the patient for possibility of trauma or specific 
medication and the answer was negative. The 
ophthalmologist referred the patient for electro-
physiological eye examinations such as visual 
evoked potential (VEP), electroretinography 
(ERG) and electrooculography (EOG). Signif-
icant delay in VEP, P100 peak and reduction 
in amplitude was observed. The ERG b-wave 
voltage was also reduced and its latency was 
increased to some extent. Also EOG was not 
normal. A literature search showed that these 
findings may be a side effect of amiodarone 
treatment in patients with heart problems. The 
ophthalmologist asked the patient for possi-
ble heart problems and amiodarone treatment 
and the patient response was positive. The 
ophthalmologist contacted the patient’s car-
diologist and discontinued the amiodarone 
medication with his permission. The patient 
complaints subsided and the only complain 
left was slight dim vision one week later. 
Discussion
Schmidt et al., 3 examined six patients with 
mean age of 71.7 years (five men, one woman) 
who were treated with amiodarone. They found 
that one patient had no visual disturbances 
and a second patient had no permanent chang-
es of the optic nerve because treatment with 
amiodarone was discontinued in time and in 
one patient an abnormal blue color vision was 
noticed 3. Swelling of the optic disc completely 
disappeared in five patients after discontinuing 
the drug, one patient revealed a posterior isch-
emic optic neuropathy (PION), in two patients 
a unilateral change of the optic disc occurred, 
and finally in three patients a severe irreversible 
lesion of the optic nerve was found at follow-up 
examinations 3. Domingues et al., 4 studied 14 
patients under long term amiodarone therapy 
using pattern reversal visual evoked poten-
tial and found a significant prolongation in la-
tency and reduction in amplitude of VEP, P100 
peak in comparison with the same parameters 
in normal population. Shaikh et al., 5 studied 
electrophysiological changes in patients un-
dergoing amiodarone treatment using multifo-
cal and full-field ERG. Their patients had re-
ceived amiodarone at various dosages ranging 
from 100 mg to 800 mg daily for at least 15 
months. No patients were found to have
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significant vision loss. Multifocal and full-field 
ERG were mostly unremarkable, and the mildly 
subnormal findings in few patients showed no con-
sistent pattern to suggest a toxic cause due to drug.
Conclusion
We recommend that every patient being treated
with amiodarone should be observed by an 
ophthalmoscope and color vision examination 
at regular intervals should be performed. 
Drug should be terminated if eye side effects 
are observed after consultation with the patient’s 
cardiologist.
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